A detailed history of New Edge Wealth, LLC transactions in Dexcom Inc stock. As of the latest transaction made, New Edge Wealth, LLC holds 8,141 shares of DXCM stock, worth $607,969. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,141
Previous 34,998 76.74%
Holding current value
$607,969
Previous $3.97 Million 86.27%
% of portfolio
0.01%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$64.0 - $116.06 $1.72 Million - $3.12 Million
-26,857 Reduced 76.74%
8,141 $545,000
Q2 2024

Aug 01, 2024

SELL
$110.31 - $140.45 $13,347 - $16,994
-121 Reduced 0.34%
34,998 $3.97 Million
Q1 2024

May 06, 2024

SELL
$114.22 - $140.1 $319,016 - $391,299
-2,793 Reduced 7.37%
35,119 $4.87 Million
Q4 2023

Jan 29, 2024

BUY
$75.49 - $124.16 $2.3 Million - $3.78 Million
30,440 Added 407.39%
37,912 $4.7 Million
Q3 2023

Nov 08, 2023

BUY
$86.06 - $137.93 $285,977 - $458,341
3,323 Added 80.09%
7,472 $697,000
Q2 2023

Aug 09, 2023

SELL
$112.47 - $130.98 $449 - $523
-4 Reduced 0.1%
4,149 $533,000
Q1 2023

May 08, 2023

BUY
$104.0 - $122.92 $13,624 - $16,102
131 Added 3.26%
4,153 $482,000
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $2,804 - $4,048
33 Added 0.83%
4,022 $455,000
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $717,002 - $884,444
-9,391 Reduced 70.19%
3,989 $321,000
Q2 2022

Aug 09, 2022

BUY
$67.99 - $132.89 $739,799 - $1.45 Million
10,881 Added 435.41%
13,380 $997,000
Q1 2022

May 10, 2022

BUY
$94.08 - $130.2 $9,690 - $13,410
103 Added 4.3%
2,499 $1.28 Million
Q4 2021

Jan 31, 2022

BUY
$129.87 - $162.82 $54,155 - $67,895
417 Added 21.07%
2,396 $1.29 Million
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $97,212 - $130,436
911 Added 85.3%
1,979 $1.08 Million
Q1 2021

May 13, 2021

BUY
$84.79 - $104.74 $90,555 - $111,862
1,068 New
1,068 $384,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track New Edge Wealth, LLC Portfolio

Follow New Edge Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Wealth, LLC with notifications on news.